Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...

India on Wednesday reaffirmed its commitment to global pharmaceutical standardisation and regulatory convergence.

The Nifty Pharma index closed on a positive note on Thursday. Shares of Abbott India Ltd.(up 4.61 per cent), Natco Pharma Ltd ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, ...

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

India's trade surplus with the US and its reliance on American trade policy for US dollar earnings make it a key player.

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...